Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 18.59 Billion | USD 33.32 Billion | 6.70% | 2023 |
The global organ transplantation market size was worth around USD 18.59 billion in 2023 and is predicted to grow to around USD 33.32 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.70% between 2024 and 2032.
Organ transplantation refers to the process that allows a living or deceased donor to give a functional organ to another patient. During organ transplantation, surgeons remove a healthy organ from the donor and transfer it to another patient who requires the organ for a healthy life. Organ transplantation is a critical medical procedure that can be carried out only by authorized medical experts. It is also one of the most widely regulated segments of the medical care industry.
Some of the most common organs that can be transplanted to another patient include kidneys, liver, heart, and lungs. In most cases, donors participating in organ transplantation are deceased people who have volunteered for organ donation in case of their death.
However, family members may also decide on behalf of the deceased person if they wish to donate the organs. According to medical experts, organ donation and transplantation can save many lives. However, the industry is facing a scarcity of organ donors.
In addition to this, there is a growing number of illegal organ transplantation activities which is further impacting the overall growth rate in the industry. During the forecast period, organ transplantation is expected to generate more revenue with improved awareness and rising innovation in terms of technologies required for successful organ transplantation.
Growing number of patients worldwide requiring new organs may drive the market demand rate
The global organ transplantation market is projected to grow due to the rising number of patients worldwide requiring new organs. According to the Cleveland Clinic, the list of organs that can be donated after a person’s death includes the intestines, heart, uterus, pancreas, kidney, lungs, and liver.
Furthermore, the list also includes tissue types that can be transplanted into another patient including corneas, bone, skin, heart valves, ligaments, nerves, hands, cartilage, and bone marrow. Organ failure is a common condition occurring in a growing number of the general population. It deals with a vital organ in the body failing to perform as expected. It can either be a sudden or gradual process. The common symptoms of organ failure are fast or shallow breathing, loss of appetite, weakness, fever, irregular heartbeat, and persistent abdominal or chest pain. Several causes are associated with organ failure.
For instance, certain chronic diseases such as chronic kidney diseases, chronic respiratory conditions, chronic degenerative brain diseases, and chronic liver diseases can cause respective organs to fail. On the other hand, traumatic injuries can also impact the overall functioning of a critical organ in the body.
According to market research, the Indian market witnessed over 18,000 organ transplants in 2023. On the other hand, Organ Donor estimates that more than 170 million in the US have registered as organ donors. Such statistics are a positive indication of growing revenue in the industry for organ transplantation.
High cost of surgeries and lack of sufficient infrastructure to limit the industry expansion rate
The global market for organ transplantation is expected to be restricted due to the high cost of the procedure. Organ transplantation is a highly sensitive process carried out by medical experts only. Furthermore, finding the right organ donor for every patient is a time-consuming process due to the long list of protocols that medical professionals must follow before the surgery.
According to the National Institutes of Health (NIH), the average cost of a kidney transplant in the US is around USD 442,500. Furthermore, the presence of strict regulatory protocols and a lack of sufficient infrastructure can dilute the total revenue for the industry.
Increasing government initiatives to promote the industry will generate growth opportunities
The global organ transplantation industry is expected to generate growth opportunities due to the rising support from the regional governments. For instance, in October 2024, Lithuania hosted the European Day for Organ, Tissue, and Cell Donation. The powerful initiative focuses on driving awareness around organ donation. It is powered by the European Directorate for the Quality of Medicines & Health (EDQM) of the Council of Europe.
In July 2024, Hungary, which is currently the president of the Council of the EU, emphasized the need to develop new solutions for improving organ donations in the region. One of the ideas proposed by the country is facilitating organ donation between member states. Furthermore, the country leaders also highlighted the need for reducing standards to be qualified as donors thus increasing the number of people that can participate in organ transplantation activities.
Technological growth in the industry has the potential to reshape the industry
The global organ transplantation market can benefit from the growing use of advanced technologies to ease the process of organ donation and further transplant. In September 2024, scientists at UC Davis Health started working on a novel technique to ease the transplant waiting list.
The researchers are working on ex vivo normothermic perfusion which will allow kidneys earlier considered unsuitable for transplant to be used during organ transplantation. The donor pool is expected to greatly benefit if the new solution proves successful.
Growing case of illegal organ transplants is a major challenge for the industry players
The global industry for organ transplantation is expected to be challenged by the rising number of cases related to illegal or unauthorized organ transplantation. Major economies including developing nations are registering an increased number of organ trafficking, especially from countries with economic and social crises.
According to World Health Organization (WHO) reports, around 5000 illegal organ transplantation surgeries were carried out in 2007. The number has increased since then. Managing and preventing organ trafficking is crucial to ensuring higher growth in the organized sector.
Report Attributes | Report Details |
---|---|
Report Name | Organ Transplantation Market |
Market Size in 2023 | USD 18.59 Billion |
Market Forecast in 2032 | USD 33.32 Billion |
Growth Rate | CAGR of 6.70% |
Number of Pages | 223 |
Key Companies Covered | Medtronic, Novartis AG, BioLife Solutions Inc., TransMedics Inc., 21st Century Medicine, AbbVie Inc., Teva Pharmaceuticals, Veloxis Pharmaceuticals, Zimmer Biomet, Stryker, Organ Recovery Systems, Roche, Paragonix Technologies, Arthrex Inc., Sanofi, and others. |
Segments Covered | By Organ Type, By Condition, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global organ transplantation market is segmented based on organ type, condition, and region.
Based on the organ type, the global market segments are heart transplant, kidney transplant, pancreas transplant, liver transplant, and lung transplant. In 2023, the highest growth was listed in the kidney transplant segment. This type of organ transplantation can be carried out using a living donor as well. Furthermore, the growing number of cases related to kidney failure is helping the segment thrive. In 2022, over 24000 kidney transplants were carried out in the US.
Based on the condition, the global market segments are type 1 diabetes with kidney failure, heart failure & coronary artery disease, liver cirrhosis & hepatitis, chronic kidney disease (CKD), and chronic obstructive pulmonary disease (COPD). According to market research, over 10.01% of the world population suffers from chronic kidney disease. CKD was the leading revenue generator in 2023. Heart failure & coronary artery disease are also widely prevalent worldwide fueling the demand for heart transplant surgeries.
Europe is projected to emerge as the highest revenue generator during the forecast period
The global organ transplantation market will be led by Europe during the forecast period. The regional revenue is driven by the presence of a robust organ transplantation infrastructure across major European countries. Spain, for instance, is world-renowned for conducting kidney transplants. Other leading countries around Europe promoting organ donation include Portugal, Croatia, France, the United Kingdom, and Sweden.
In 2023, Spain broke its own records for organ transplantation. The country reported the highest number of organ donations standing at nearly 49 donors per million people. Furthermore, the growing initiatives by European leaders to promote awareness around organ donation and transplantation will further facilitate regional market expansion.
In June 2022, a team of Swiss surgeons made a major breakthrough after transplanting a donor liver which had been stored outside the body for three days with the aid of novel technology. The team leveraged the offerings of normothermic perfusion machines that are known to replicate the human body by continuously supplying blood to the organ. The surge in technology-led innovation to improve the outcomes of organ transplantation across Europe will further facilitate a positive market growth rate.
The global organ transplantation market is led by players like:
The global organ transplantation market is segmented as follows:
By Organ Type
By Condition
By Region
FrequentlyAsked Questions
Organ transplantation refers to the process that allows a living or deceased donor to give a functional organ to another patient.
The global organ transplantation market is projected to grow due to the rising number of patients worldwide requiring new organs.
According to study, the global organ transplantation market size was worth around USD 18.59 billion in 2023 and is predicted to grow to around USD 33.32 billion by 2032.
The CAGR value of the organ transplantation market is expected to be around 6.70% during 2024-2032.
The global organ transplantation market will be led by Europe during the forecast period.
The global organ transplantation market is led by players like Medtronic, Novartis AG, BioLife Solutions Inc., TransMedics Inc., 21st Century Medicine, AbbVie Inc., Teva Pharmaceuticals, Veloxis Pharmaceuticals, Zimmer Biomet, Stryker, Organ Recovery Systems, Roche, Paragonix Technologies, Arthrex Inc. and Sanofi.
The report explores crucial aspects of the organ transplantation market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed